Vascepa is a prescription medication used to reduce triglyceride levels in adults with high triglycerides. It contains the active ingredient icosapent ethyl and is manufactured by Amarin Corporation. According to the sources provided, there is currently no generic version of Vascepa available on the market. The patent for Vascepa was set to expire in July 2020 [1], and several pharmaceutical companies were working on developing generic versions of the drug [3]. However, as of November 2020, no generic versions of Vascepa have been approved by the FDA [2].

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.drugs.com/availability/generic-vascepa.html
[3] https://professionals.optumrx.com/content/dam/optum3/professional-optumrx/news/rxnews/new-generics/newgenerics_vascepa_2020-1106.pdf